Cancer Immunotherapy Manipulation of co-stimulatory signals Enhancement of APC activity Cytokine therapy Monoclonal antibody therapy.

Slides:



Advertisements
Similar presentations
Evading Immune Responses and Tumor Immunology
Advertisements

Monoclonal Antibodies
Immunological aspect of tumor
Lecture 11-Activation of naïve T cells Naïve T cells are activated in lymph nodes and spleen. Dendritic cells are key antigen presenting cells for naïve.
Immunity to tumors Tumor antigens
THE GENETIC OF CANCER Increased mitosisTumor formation Tumor suppression gene Hyperactive growth TranslocationPoint mutationAmplification Normal growth.
Tumor Immunology (Cancer) Robert Beatty MCB150 Tumors arise from accumulated genetic mutations.
T cell-mediated immunity Chapter 8
Cancer and the Immune System Amar Bhatt Shirley Masand Jaime Warmkessel Immunology Chapter 22 April 22, 2003.
118/2/2015 Cancer & the Immune System Hugh B. Fackrell.
Chapter 19 Cancer and the Immune System Dr. Capers.
What is biological therapies Biological therapy is the therapeutic use of agents derived from biological sources and affecting biologic response. Also.
Adjuvant therapy for renal cell carcinoma Dr.Mina Tajvidi oncologist.
Cancer immunology and immunotherapy. First an aside  Oncogenes and tumor suppressor genes.  Definitions anyone?  Oncogene –  Tumor suppressor gene.
TUMOR IMMUNOLOGY Objectives
Tumor Immunology Wirsma Arif Harahap Surgical Oncologist Surgery Department Andalas Medical School Wirsma Arif Harahap Surgical Oncologist Surgery Department.
Cancer vaccines are biological response modifiers. They prime the immune system to attack the cancer cells in the body. The goal is to prevent or to treat.
+ How is the cell cycle regulated? Sections 8.8 and 8.9.
A cancerous cell is caused by a faulty reproduction system. The cell continues to reproduce at a very fast rate When cells reproduce at an abnormally.
General classes of vaccines An induced mobilization of the immune response for the purpose of therapeutic benefit. Preventative: infectious agents Therapeutic:
Chapter 21 Cancer and the Immune System Dr. Capers
Unit 3 Biology: signatures of life conceptual framework
Tumor Immunology Dr.Marián Sabol, PhD. P.J. Šafárik University, Medical Faculty, Institute of Medical Microbiology Tr. SNP 1, Košice, Slovakia.
Chapter 17 Immunoregulation
Tumor immunotherapy 张沛张书铭 张黎明 赵宸 赵世刚 Tumour Immunotherapy: questions Can immune stimulators combat cancer? Which forms of immunotherapy can be used?
By: Sara Ibrahim Tel. # Cancer and The Immune System.
DC vaccine & Anti-tumor “ 生命之树 ” 课题组: 孔琰 唐跃 田亚楠 孔琰 唐跃 田亚楠 王超 王京 王欠欠 王超 王京 王欠欠.
IMMUNODEFICIENCIES AND TUMOR IMMUNOLOGY
Chapter 20 Tumor Immunology. Introduction Part Ⅰ Tumor antigens Part Ⅱ Immune response to tumors Part Ⅲ Mechanism of tumor escape from immune surveillance.
Maude et al. BLOOD, 25 JUNE 2015 x VOLUME 125, NUMBER 26
Cancer Immunotherapy. Type of tumor: -Non-invasive (benign) - Invasive (malignant)
Basic Immunology of the Mouse (and Human) Nicholas P. Restifo, MD October 19, 2015.
Immunotherapy (Cancer therapy with T-Cells)
Cells of the Immune System Lymphoid lineage: –Central cells of the IS –responsible for adaptive IR –Provide diversity, specificity, memory,self – nonself.
Medical Immunology 吉林大学基础医学 院免疫学教研室 1 Overview of Immunology Organs and tissues Cells Molecules - Antibodies - Complement - Cytokines - MHC Components.
Host Defense Against Tumors (Tumor Immunity)
NAJRAN UNIVERSITY College of Medicine NAJRAN UNIVERSITY College of Medicine Microbiology &Immunology Course Lecture No. 17 Microbiology &Immunology Course.
1 Steven A. Feldman, Ph.D. Surgery Branch, NCI MEASUREMENT CHALLENGES FOR CAR-T BIOMANUFACTURING January 29, 2016 Adoptive Cell Therapy for the Treatment.
Cancer Immunotherapy Presented by Md. Farhadur Rahman Phase A Student Department of Microbiology BSMMU.
Immunological tolerance and immune regulation -- 1
 Dendritic cells (DCs) are immune cells forming part of the mammalian immune system. Their main function is to process antigen material and present it.
Tumor Immunology. Key questions:  How do tumor cells evade the immune system  What are the main immune responses to tumor cells?  What are the potential.
ایمونولوژی سرطان پزشکی -آذرماه 1387.
Cancer and the Immune System
Immunological tolerance and immune regulation -- 1
Objectives Introduction Ags expressed by cancer cells
HOST DEFENCE AGAINST TUMORS:
Dr. Peter John M.Phil, PhD Atta-ur-Rahman School of Applied Biosciences (ASAB) National University of Sciences & Technology (NUST)
Cancer and the Immune System
Immunotherapy of hepatocellular carcinoma
Advances in Specific Immunotherapy for Prostate Cancer
Heating is a multifunctional adjuvant that affects tumor microenvironment through several intrinsic and extrinsic mechanisms, which could enhance immunotherapy.
Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy by Claudia Rossig,
Volume 44, Issue 6, Pages (June 2016)
ADOPTIVE T CELL THERAPY
Cancer Immunotherapy Presented by Md. Farhadur Rahman Phase A Year II
Volume 20, Issue 5, Pages (May 2012)
Volume 27, Issue 2, Pages (August 2007)
Tumor immunology.
Albert J. Czaja, Michael P. Manns  Gastroenterology 
Chie Kudo-Saito, Hiromi Shirako, Tadashi Takeuchi, Yutaka Kawakami 
Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
Vaccines for Lung Cancer
Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response  Arup Garu, Gopikrishna.
Volume 44, Issue 6, Pages (June 2016)
Positive correlations between disease course and treatment-induced immune responses. Positive correlations between disease course and treatment-induced.
Distributions of CD4, Th1, and Th2 in adults (n = 16; A) and children (n = 50; B). Distributions of CD4, Th1, and Th2 in adults (n = 16; A) and children.
CD8+ depletion and IFN-γ–deficient myeloid cells and lung metastasis inhibition in Tgfbr2MyeKO mice. CD8+ depletion and IFN-γ–deficient myeloid cells and.
BATF3-expressing professional antigen-presenting cells (DC) are able to cross-present tumor antigen (TA) by channeling material taken up from their environment.
Presentation transcript:

Cancer Immunotherapy Manipulation of co-stimulatory signals Enhancement of APC activity Cytokine therapy Monoclonal antibody therapy

Co-stimulatory signals Possibility of transfecting irradiated (inactivated) tumor cells with B7 co-stim genes –Perhaps a similar vaccine may prevent metastasis after surgical removal of tumors Also, melanoma antigens shared by a number of different tumors

Enhancement of APC activity Transfect tumor cells with gene encoding GM-CSF  reinfuse to patient to stimulate DC’s to enhance Ag presentation to TH’s and Tc’s Or culture patient DC’s w/ GM-CSF, TNF-a, and IL-4  expand DC population Or use adjuvants of (Mb, Cp) to stimulate MØ to better activate TH cells???

Cytokine therapies From cloned genes for various cytokines (IFN’s, TNF’s, etc.)…. still a work in progress IFN’s – daily injections of IFN-a – partial/complete tumor regression All 3 types of IFN >MHC I on tumor cells; >CTL response All 3 appear to inhibit cell division in tumor cells IFN-y stim activity of Tc’s, MØ, and NK cells

Cytokine therapies (cont’d) TNF’s – both TNF-a/B show direct effects on tumor cells, while sparing normal cells –TNF-a shows anti-angiogenic affects to tumors ↓blood flow and oxygen

Monoclonal antibodies